Cell Therapy Pioneers Across Southeast Asia Gather In A Revolutionary Convergence in Singapore: The 3rd CAR-TCR: Cell Therapy Summit Asia
Prepare for a seismic shift in the world of cell therapy as Singapore becomes the epicentre of ground-breaking innovation at the 3rd CAR-TCR: Cell Therapy Summit Asia. From November 12-14, 2024, visionaries and leaders from across the APAC region will gather to forge the future of healthcare, where cutting-edge science meets strategic collaboration.
As Asia emerges as a global powerhouse in cell therapy, this summit is set to be the most pivotal gathering yet. Attendees will explore how Asia is accelerating the commercialization of next-generation cell therapies, with deep dives into regulatory advances, manufacturing optimization, and the revitalization of investment in Southeast Asia.
Featuring industry titans like Hao Shen of Fosun Kite Pharma and James Li of JW Therapeutics, this summit promises insights into the latest breakthroughs and strategies for overcoming the most pressing challenges in the field. Sessions will unveil robust strategies to attract investment, optimize market access, and foster cutting-edge cancer treatments, positioning Asia as the leader in global cell therapy development.
Don’t miss your chance to be part of history in the making. The 3rd CAR-TCR: Cell Therapy Summit Asia is where the future of medicine unfolds.
For more information on how to secure your free pass, visit the 3rd CAR-TCR: Cell Therapy Summit Asia.
Presented By:
Rochelle Samuel
Senior Program Director
Hanson Wade
